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Abstract
Purpose The study aimed to test the hypothesis that hospital
electronic prescribing and medicine administration system
(HEPMA) implementation impacted patient discharge letter
quality, nature and frequency of prescribing errors.
Method A quasi experimental before and after retrospective
case note review was conducted in one United Kingdom dis-
trict general hospital. The total sample size was 318 (random
samples of 159 before and after implementation), calculated to
achieve a 10% error reduction with a power of 80% and
p < 0.05. Adult patients discharged after ≥24-h inpatient stay
were assessed for discharge information documentation qual-
ity using a modified validated discharge document template.
Prescribing errors were classified as medicine omissions,
commissions, incorrect dose/frequency/duration, drug interac-
tions, therapeutic duplications or missing/inaccurate allergy
information. Post-implementation assessments were under-
taken 4 months following HEPMA implementation. Error se-
verity was determined by a multidisciplinary panel consensus
using the Medications at Transitions and Clinical Handoffs
(MATCH) study validated scoring system.
Results There were no statistically significant differences in
patient demographics between the pre- and post-
implementation groups. Discharge information documenta-
tion quality improved; allergy documentation increased from
11 to 159/159 (p < 0.0001). The number of patients with
prescribing errors reduced significantly from 158 to 37/159
(p < 0.001). Prescribing error category incidence identified
in pre-implementation patients was reduced (e.g. omission
incidence from 66 to 18/159 (p < 0.001)), although a new
error type (sociotechnical [errors caused by the system]) was
identified post-implementation (n = 8 patients). Post-
implementation prescribing errors severity rating identified
8/37 as likely to cause potential patient harm.
Conclusion HEPMA implementation was associated with im-
proved discharge documentation quality, statistically signifi-
cant prescribing error reduction and prescribing error type
alteration. There remains a need to be alert for potential pre-
scribing errors.
Keywords HEPMA . Prescribing error . Sociotechnical error
Introduction
Hospital electronic prescribing and medicines administration
(HEPMA) systems were defined by the Department for Health
in England in 2007 as ‘the utilisation of electronic systems to
facilitate and enhance the communication of a prescription or
medicine order, aiding the choice, administration and supply of
a medicine through knowledge and decision support and provid-
ing a robust audit trail for the entire medicines use process’ [1].
UK government strategy recommends HEPMA system imple-
mentation, with National Health Service (NHS) England and
NHS Scotland policies committed to HEPMA as a future e-
health model in all secondary healthcare settings [2, 3].
Reported advantages of electronic prescribing systems in-
clude increased patient safety by prescribing error reduction.
The UK Health Foundation stated that implementation of an
electronic prescribing system incorporating decision support
functionality could realise a 50% prescribing error reduction
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[4]. These systems also have the capacity to create prescrip-
tions at the point of patient discharge from secondary care [5].
Electronic systems are, not without their limitations, having
been shown to lead to ‘sociotechnical errors’, defined as those
‘occurring at the point where the system and the professional
intersected and would not have occurred in the absence of the
system’ [6].
In the UK, implementation of electronic prescribing sys-
tems is variable. A survey of English hospitals in 2011 report-
ed that while 48% of hospitals had implemented standalone
electronic discharge systems, only 13% had implemented in-
tegrated inpatient and discharge electronic prescribing [7].
Reduction in inpatient prescribing errors has been demonstrat-
ed with electronic prescribing systems [8, 9]. However, there
has been limited study of prescribing error alteration in dis-
charge prescriptions. A narrative literature review of discharge
information communication and medicines discharge pre-
scribing errors identified four studies comparing electronic
solutions to traditional handwritten systems and five of elec-
tronic solutions with no comparison. These studies demon-
strated inconsistent results with improved, unchanged or re-
duced medicine information accuracy [10]. Notably, none of
the study sites had implemented the UK HEPMA systems.
Healthcare Improvement Scotland state that HEPMA
systems need to be at least as safe as the traditional
paper systems they replace [11]. Guidance on hospital
medicines discharge documentation requirements are
provided by two UK bodies, the Royal Pharmaceutical
Society (RPS) and the Scottish Intercollegiate Guideline
Network (SIGN) [12, 13]. The RPS guidance proposes
core content for medicines information communication
on hospital discharge, including a mandatory require-
ment for medicines change information to be recorded
[12]. SIGN guidance defines the ideal content of hospi-
tal discharge documentation including a standard tem-
plate with 29 required sections [13]. In 2014, NHS
England identified specific issues concerning discharge
medicines information communication which resulted in
widespread dissemination of a patient safety alert to
highlight the importance of essential information com-
munication on discharge [14]. Medicine-related events
are the most common adverse event occurring following
hospital discharge, with evidence of perpetuation of dis-
charge prescribing errors associated with a moderate
potential for harm [15]. Failure to recognise these ad-
verse events is a contributory factor for hospital read-
mission [16].
Currently, there is a lack of published evidence relating to
HEPMA impact on discharge medicines information commu-
nication and prescribing error prevalence.
The aim of this study was to test the hypothesis that
HEPMA implementation impacted discharge letter quality,
nature and frequency of prescribing errors.
Methods
Design
A quasi experimental, before and after retrospective case note
review design was adopted.
Setting
The study was undertaken in a 560 bedded district
general hospital (DGH) in the UK. The selected
HEPMA system was a commercial ly avai lable
standalone system; HEPMA implementation com-
menced in October 2013 and was completed in
September 2014. Prior to HEPMA implementation,
manual handwritten immediate discharge letters (IDLs)
were prepared by either a medical prescriber or an
advanced nurse practitioner transcribing diagnostic in-
formation from handwritten case notes and inpatient
chart(s). Post-HEPMA implementation, both the inpa-
tient prescription chart and the IDL were prepared
electronically while the case notes remained handwrit-
ten. The IDL is prepopulated with information such as
demographics and allergies. Discharge medicines can
be selected from those prescribed as an inpatient and
those to be commenced at the point of discharge
added. Diagnostic and other clinical information is
added by the clinician completing the IDL.
Sampling
The sample size calculation was based on anticipated
baseline error rate of 17.5% [10]. The aim was to
achieve a 10% error reduction with a power of 80%
and p < 0.05. The total sample size was 318, compris-
ing random samples of 159 before and af te r
implementation.
Patient inclusion criteria were as follows:
& Discharged between April to June 2013 (pre) and
February to April 2015 (post)
& ≥16 years
& Discharged from hospital after an inpatient stay of at least
24 h
Patient exclusion criteria were as follows:
& Mental health, maternity and paediatric wards (HEPMA
not implemented or implemented prior to the study)
& No medicines prescribed at discharge
& Inter-hospital transfer
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Pre-implementation data collection
Case notes were reviewed retrospectively by the principal in-
vestigator, an experienced clinical pharmacist, with a focus on
information content and presence of prescribing errors on the
handwritten IDL by scrutinising clinical notes, inpatient pre-
scription charts and IDLs. Data were extracted onto a data
collection tool, which was a modified version of the SIGN
discharge document template [13]. Variables documented
were age, gender, general practitioner details, hospital consul-
tant details, discharge ward, discharge specialty, length of stay,
discharge day of week, primary diagnosis, secondary diagno-
sis, significant operations/procedures, allergies, number of
medicines prescribed on IDL, and designation of clinician
completing and IDL. An independent clinical pharmacist con-
firmed the reliability of data extraction in a random sample of
10% of patients.
Data of primary diagnosis, secondary diagnosis and signif-
icant operations/procedures were not assessed for accuracy,
merely recorded as present or absent in accordance with the
approach of Callen et al. [17].
Medicines prescribed on discharge were compared to the
inpatient list to identify any discrepancies.
The definition of prescribing error of Dean et al. was
adopted, ‘a prescribing error occurs, when as a result of a
prescribing decision or prescription writing process, there is
an unintentional reduction in the probability of treatment be-
ing timely and effective or increase in the risk of harm’ [18].
Prescribing error types were classified as medicine omission,
medicine commission, incorrect dose, incorrect frequency, in-
correct duration, drug interaction, therapeutic duplication,
missing allergy and inaccurate allergy, as described in
Table 1. Reliability of error categorisation in a random sample
of 10% was confirmed by an independent clinical pharmacist.
Post-implementation data collection
A similar method was adopted for the post-implementation
phase. Prescribing errors were identified and categorised as
before, with the addition of sociotechnical errors in the post-
implementation group. Examples of sociotechnical errors in-
clude incorrect selection of medicine formulation [6, 19].
Following data extraction, one medical consultant and one
clinical pharmacist scored prescribing error severity. The pan-
el was provided with information about each prescribing error
as per previous studies [20]. The panel were also provided
with a copy of the severity scoring guidance which consisted
of a validated scoring system developed byGleason et al. [21].
The severity ratings were as follows:
1. No potential harm
2. Monitoring or intervention potentially required to pre-
clude harm
Table 1 Error type classification
Error type Description Exclusion
Omission Medicine omitted from
IDL currently
prescribed on inpatient
chart. Medicine
administered
preceding/discharge
day. For example
documentation of ‘no
changes to routine
medicines’.
Medicine not usually
required on discharge,
for example antiemetic
injection.
Commission Medicine prescribed on
IDL not on
pre-admission list.
Medicine not
administered
preceding/discharge
day, e.g. cyclizine
(antiemetic) prescribed
as a precaution but
never administered.
Explanatory note
documented for
medicine requirement.
Incorrect dose Discrepancy between dose
on inpatient chart and
IDL or no dose
documented, e.g.
carvedilol noted as
19 mg instead of
18.75 mg
Explanatory note
documented regarding
dose change.
Incorrect
frequency
Discrepancy between
frequency documented
on inpatient chart and
IDL or none
documented. For
example, as required
medicines prescribed
without specified time
interval.
Explanatory note
documented regarding
frequency change.
Incorrect
duration
Discrepancy between
duration documented on
inpatient chart and IDL
or no documented
duration provided.
Explanatory note
documented regarding
duration change.
Drug
interaction
A drug interaction
recorded as a serious
interaction in current
edition of British
National Formulary.
Appropriate to
co-prescribe with suit-
able monitoring.
Therapeutic
duplication
More than one medicine
prescribed from same
therapeutic group.
Co-codamol and
tramadol co-prescribed.
Protocol exists to evidence
prescribing action.
Missing allergy Allergy documented on
inpatient chart and/or
patients’ case notes but
not on IDL. Nil known
drug allergy (NKDA)
missing from IDL.
Explanatory note
documented regarding
allergy information.
Inaccurate
allergy
Discrepancy between
allergy documented on
inpatient chart and/or
patients’ case notes and
IDL.
Explanatory note
documented in case
note regarding allergy
information change.
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3. Potential harm
The panel met and discussed each error in turn, assigning a
severity score. If consensus was not achieved, the error was
referred to an independent medical consultant for further
assessment.
Data analysis
Data were input to Statistical Packages for Social Sciences
(SPSS) version 21.0, and analysed using descriptive statistics,
normality tests and inferential statistics [22]. The Shapiro-
Wilk normality test was applied to determine data distribution;
Mann Whitney U test was used for non-parametric variables
including patient length of stay and discharge specialty.
Categorical variables were analysed using chi-square test for
data with values greater than zero and Fisher exact test for data
including a count of zero. The accepted level for significance
was p < 0.05.
Governance
The study was approved by the ethical review panel of a UK
university; NHS ethics was not required as it was considered a
‘service evaluation’. Caldicott guardian approval was obtain-
ed to access patient confidential information [23].
Results
Data were found to follow a non-parametric distribution.
There were statistically significant differences between groups
as depicted in Table 2 (p > 0.05). The median age was 60 years
pre-implementation and 59 post-implementation, with gender
consistent at 57% female. The most common length of stay
was 2 days for both groups and discharge specialty was con-
sistent with 47% medical specialties; more medicines were
prescribed post-implementation (p = 0.023). There was a sta-
tistically significant improvement in some aspects of docu-
mentation (patient’s GP details, allergy information, grades
of staff); no impact on others (hospital consultant, relevant
secondary diagnosis, signature and full name printed); while
certain sections were associated with reduced information
documentation (diagnosis and procedures/operations)
(Table 3).
Table 4 gives the comparison of prescribing errors pre- and
post-HEPMA implementation. There was a statistically signifi-
cant reduction in the number of patients with a prescribing error
post-HEPMA implementation, a reduction from 158 (99.4%) to
37 (23.3%) patients (p < 0.001.). The prevalence of all error
types was reduced, being statistically significant for omitted
medicines, medicine commission, incorrect doses, incorrect fre-
quencies, incorrect durations and missing allergies (Table 4).
Sociotechnical errors were attributed to prescriber selection fail-
ure for formulations and administration route for eye drops.
Multiple error types were detected in 41.5% (n = 66) pre-
implementation patients reduced to 2% (n = 3) post-implemen-
tation. Multiple instances of the same error (for example, omit-
ted medicines) occurred in 56% (n = 89) pre-implementation
patients reduced to 7% (n = 11) post-implementation.
Error severity scoring
Errors were detected in 23% of post-implementation patients
(n = 37). Severity scoring results gave category 1 errors
Table 1 (continued)
Error type Description Exclusion
Sociotechnical
(post-HEP-
MA)
Error caused by HEPMA
system, e.g.
prednisolone soluble
tablets instead of plain
tablets.
Error unlikely to be caused
by HEPMA.
Table 2 Comparison of pre- and
post-implementation results Variable Pre-implementation
(n = 159)
Post-implementation
(n = 159)
Significance p
value
Age range (years) 18–102
Median 60
17–93
Median 59
0.416
Gender 57% female 57% female
Length of stay (days) 1–25
Mode 2
1–33
Mode 2
0.232
Discharge specialty Medical 47%
Surgical 33%
Medical 47%
Surgical 30%
0.688
Range of number of discharge
medicines
0–25
Median 5.0
0–18
Median 6.0
0.023
Total number of IDL prescribed
medicines
872 1018 0.023
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(causing no potential harm) in 8 (22%) of patients with errors,
category 2 errors (monitoring or intervention potentially re-
quired to preclude harm) in 19 (53%) and category 3 errors
(likely to cause potential patient harm) in only 8 (22%).
Table 5 provides example error descriptions with associated
score. Severity score 1 errors included incorrect formulation
selected and 5 days of cyclizine supplied on discharge when
none had been administered during the inpatient stay.
Assessors agreed for all severity scoring.
The null hypothesis was rejected; HEPMA implementation
positively impacted discharge letter quality, with a reduction
in prescribing error frequency and severity of errors.
1=no potential harm, 2=monitoring or intervention poten-
tially required to preclude harm, 3=potential harm
Discussion
Key findings
The key study findings relate to discharge letter quality and
the nature and type of prescribing errors. HEPMA implemen-
tation resulted in an improvement in information content and
accuracy. An improvement for almost all assessed SIGN
guideline criteria was a consequence of HEPMA implemen-
tation [13]. HEPMA implementation significantly reduced the
number of patients with prescribing errors (p < 0.001). Allergy
information documentation improved with missing allergy in-
formation practically eliminated (p < 0.0001). Medicine
omission was the most frequent error type post-imple-
mentation, although the incidence was significantly re-
duced compared to pre- implementa t ion leve ls
( p < 0 . 0 0 1 ) . E r r o r s r e l a t e d t o t h e s y s t em
(sociotechnical errors) were detected in 5% post-
implementation patients (n = 8). HEPMA prescribing
errors were categorised as potentially associated with
harm in 5% patients (n = 8).
Strengths and weaknesses
The study strengths include application of a consistent
approach by use of an adapted validated tool and ap-
propriate study design to minimise bias wherever pos-
sible. Biases minimised were measurement bias by use
of a validated tool and non-response and sampling
biases by use of a random patient sample and by sys-
tematic application of the sample. There are, however,
Table 3 Comparison of
documented information on IDL Comparison of number and percentage of
patients with required information
Pre-HEPMA
n = 159 N (%)
Post-HEPMA
n = 159 N (%)
Chi-
square
p value
Patient’s GP details 89 (56.0) 157 (98.7) 83.019 <0.001
Hospital consultant 154 (96.9) 159 (100) Fisher
ex-
act*
0.0605
Diagnosis 153 (96.2) 116 (73.0) 33.028 <0.001
Relevant secondary diagnosis 48 (30.2) 49 (30.8) 0.015 0.902
Procedures/operations 99 (62.3) 62 (39.0) 17.223 <0.001
Allergy information 11 (6.9) 159 (100) Fisher
exact
<0.0001
Signature 159 (100) 159 (100) Fisher
exact
1.0
Full name printed 157 (98.7) 159 (100) Fisher
exact
0.4984
Grade of staff 64 (40.2) 159 (100) Fisher
exact
<0.0001
Table 4 Comparison of prescribing errors
Comparison of number and
percentage of patients with
prescribing errors
Pre-
HEPMA
n = 159 N
(%)
Post-
HEPMA
n = 159 N
(%)
Chi-
square
p
value
Patients with errors
including omitted allergy
information
158 (99.4) 37 (23.3) 194.115 <0.001
Patients with errors
excluding NKDA
134 (84.3) 37 (23.3) 119.03 <0.001
Omitted medicines 66 (41.5) 18 (11.3) 37.275 <0.001
Medicine commissions 10 (6.3) 1 (0.6) 7.627 0.006
Incorrect doses 14 (8.8) 1 (0.6) 11.824 <0.001
Incorrect frequencies 30 (18.9) 2 (1.3) 27.241 <0.001
Incorrect durations 43 (27.0) 3 (1.9) 40.665 <0.001
Drug interactions 7 (4.4) 1 (0.6) 4.616 0.032
Therapeutic duplications 5 (3.1) 4 (2.5) 0.114 0.736
Missing allergies 154 (96.9) 2 (1.3) 290.72 <0.001
Incorrect allergies 2 (1.3) 0 Fisher
exact
0.498
Sociotechnical error 0 8 (5.0) Fisher
exact
0.007
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several limitations hence the study findings should be
interpreted with caution. While a randomised control
trial would be the ideal study design, this was not
possible due to the nature of HEPMA implementation
within the study setting. Other limitations were the
before and after design which resulted in different pa-
tients in the two phases. Severity scoring assessment is
noted to be subjective and the panel was limited to the
perspectives of one medical consultant and one senior
pharmacist. There may have been other confounders
between the two study periods impacting the findings.
These included changes in medical staff and other
changes in operational processes. Furthermore, there
was no consideration of actual patient harm as a result
of prescribing errors.
Interpretation
This study demonstrated improvements to discharge informa-
tion content and accuracy while previous studies had reported
inconsistent results when moving to electronic systems, al-
though disparate methods were employed in the different stud-
ies [17, 24–26]. The documentation of diagnosis in the desig-
nated section of the IDL was reduced although frequently, this
information was incorporated into the clinical progress sec-
tion. A similar finding was reported by Callen et al. when they
compared electronically produced letters to handwritten ones
[24]. Prescribing error frequency was reduced as a conse-
quence of HEPMA implementation. HEPMA confers auto-
matic import of information from the inpatient chart to the
IDL which is consistent with a recommendation by
Kriplalani et al. that ‘hospitals should use information tech-
nology to extract information into discharge summaries to
ensure accuracy (e.g. medication names and doses) and to
facilitate rapid completion of summaries’ [27]. HEPMA im-
plementation eradicates medicine transcription for IDLs
which was predicted to reduce prescribing errors and increase
the total number of medicines prescribed on IDLs [17, 24].
Grimes et al. in an observational study reported medicine dis-
crepancies in 66% patients at hospital discharge [28]. HEPMA
Table 5 Post-HEPMA error
severity scoring examples Error description Error type Severity
score
Co-prescribed fluoxetine and amitriptyline (only taking amitriptyline prior to
admission)
Therapeutic
duplication
2
No medicines added to IDL but patient had 18 medicines prescribed and
administered as inpatient which should be continued on discharge.
Omission 3
Esomeprazole 40 mg once daily prescribed as inpatient but omitted from IDL. Omission 2
Wrong formulation of phenoxymethylpenicillin selected; syrup instead of
tablets.
Sociotechnical 1
Lantus® and Humulin S® on IDL with no frequency documented. Marked as
charted but the insulin chart would not be sent to the patient’s GP.
Incorrect
frequency
1
Simvastatin withheld during inpatient stay as co-prescribed clarithromycin.
Information documented on IDL to restart simvastatin once antibiotics
completed. Simvastatin and clarithromycin both prescribed on IDL and both
dispensed.
Drug interaction 2
5-day supply of cyclizine requested on IDL but not administered during
inpatient stay.
Commission 1
Clomipramine prescribed in morning but should be at night as per admission
medicine reconciliation. (HEPMA defaults to 10 p.m. time).
Incorrect
frequency
2
Amiodarone 200 mg tablets selected for 100 mg dose (100 mg tablets
available).
Sociotechnical 2
Commenced on zopiclone for night sedation but developed a skin rash so
stopped. Information not documented on IDL nor allergy status updated.
Omitted allergy 3
Palliative care recommended codeine and sevredol for pain as tramadol no
longer effective but all three on IDL plus dihydrocodeine.
Therapeutic
duplication
3
Meloxicam, azathioprine and sulfasalazine should be restarted at normal doses
1-week post-discharge but none prescribed on IDL and not mentioned on
IDL.
Omission 3
Tranexamic acid should be continued until clinic appointment but marked as
28-day supply with GP to continue.
Incorrect
duration
2
Omeprazole prescribed as gastrointestinal cover while on diclofenac but
information not communicated to GP so potential could be continued.
Incorrect
duration
3
Allergy information recorded as other (see medical notes). There was an
inpatient note documented as sodium benzoate causes mouth ulcers but note
not added to the IDL.
Missing allergy 2
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implementation reduced prescribing errors from 84 to 23%
patients (excluding omitted allergy information). The most
frequent post-implementation prescribing error type was omit-
ted medicines, as demonstrated in retrospective studies focus-
ing on electronic discharge systems [17, 24, 28–30].
Sociotechnical errors accounted for 10 (13%) of post-
implementation errors and therefore the HEPMA system
prevented more errors than it created. This is consistent with
inpatient electronic prescribing error occurrence detected by
incident report review [6]. Errors occurring as a consequence
of making changes to inpatient charts after preparation of
IDLs have been reported when transcribing information from
paper inpatient to electronic discharge letters [24]. A similar
error was detected post-HEPMA, despite a system alert to
indicate that the IDL also required to be changed. Thus,
HEPMA implementation has not completely eliminated pre-
scribing errors. The majority of detected prescribing errors
were classified as execution errors in Reason’s model (slips
or lapses) which generally occur due to human fallibility [20].
Hence, evidence of planning failures remained where practi-
tioners considered their erroneous actions to be correct.
Comparison with published studies indicates that error se-
verity is lower with HEPMA compared to traditional hand-
written processes. Published error severity varied and a range
of severity scoring assessments were utilised. Grimes et al.
reported error severity rates in handwritten IDLs as 47% no
harm or minor potential harm, with 53% as moderate potential
patient harm [28]. McMillan et al. assessed 88% of errors as
minor or potentially troublesome for handwritten discharge
letters [31]. Abdel-Qader et al. categorised discharge electron-
ic prescribing errors as serious 2.9%, significant 76.3% and
minor 20.8% [30].
Conclusion
This study has provided evidence that HEPMA implementa-
tion in a UK DGH hospital was associated with a statistically
significant reduction in discharge prescribing errors and sever-
ity of prescribing errors with a concurrent improvement in
discharge information content. The electronic system is not a
panacea for prescribing errors as system-related errors were
detected although with a lower error severity than pre-existing
error types.
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